Minaris
Philadelphia, PA, United States minaris.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Minaris is a cell and gene therapy CDMO and contract testing company serving therapy developers and biologics companies. It supports programs from preclinical development through commercial production with manufacturing, technology transfer, and testing operations in North America, Europe, and Asia.
Services
Cell banking
Provides cGMP cell banking services and generates research, master, and working cell banks for advanced therapy programs.
Cell therapy technology transfer
Provides structured technology transfer for cell therapy programs, including site-to-site and development-to-manufacturing transfers.
Cell therapy process development
Develops and optimizes cell therapy processes for autologous and allogeneic platforms, including closed and automated workflows.
Cell therapy analytical development
Develops analytical test methods for release and in-process control testing of cell therapy products.
Cell therapy GMP manufacturing
Provides clinical and commercial GMP manufacturing for autologous and allogeneic cell therapies.
CDMO: development & manufacturing
Viral vector process development
Develops upstream, downstream, and formulation processes for viral vectors, including AAV and lentiviral programs.
Viral vector GMP manufacturing
Provides GMP manufacturing for viral vectors across early-phase clinical and commercial supply.
CDMO: development & manufacturing
Plasmid engineering
Provides plasmid solutions, including SnapFast™ plasmids for vector and cell therapy programs.
11 more services
- TESSA® technology
- XOFLX® cell lines
- Analytical development
- Assay transfer
- Biosafety testing
- Cell line characterization
- Lot release testing
- Potency testing
- Stability testing
- Viral clearance testing
- Transmission electron microscopy (TEM)
Capabilities
- Assays and studies
- Cell therapy
- Analytical development
- Process development
- AAV
- Lentivirus
- Bioreactors
17 more
- Stability studies
- HEK293
- Antibodies
- Assay transfer
- Biosafety testing
- Cell line characterization
- Lot release
- Potency
- Stability
- Viral clearance testing
- TEM
- In vitro adventitious virus assays
- Replication competent retrovirus testing
- 9CFR viral detection assays
- Titering and viral quantification assays
- Molecular methods including NGS
- Sterility testing
- Scale and capacity
- Over 7,500 GMP batches produced
- 4 commercially experienced sites across 3 continents
- Up to 200L for development
- Up to 1,000L
- Commercial and clinical manufacturing facilities in Germany (Munich), the US (Philadelphia, PA and Allendale, NJ) and Ja
- Therapeutic areas
- Cell and gene therapy
- Biologics
- Viral vaccines
Instruments and platforms
- Transmission Electron Microscopy (TEM)
- Xuri
- Prodigy
- G-Rex
- Cell factories
- 3D bioreactors
- Hyperstacks
- Single-use bioreactor systems
Modalities and species
- Modalities
- Antibody
- Viral vector
- Cell therapy
- Gene editing
- Vaccine
- Plasmid DNA
- Species and models
- HEK293
- HEK293T
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: cell banking, manufacturing, and TEM services
ISO/IEC 17025Self-reported
Details
- Type
- CRDMO
- Address
- 400 Rouse Boulevard, Philadelphia, PA 19112
- Sites
- Philadelphia, PA, United States
- Allendale, NJ, United States
- Munich, Germany
- Yokohama, Japan
- Taufkirchen, Germany
- London, United Kingdom
- Serves
- North America, Europe, Asia, worldwide